(Q34941391)

5 August 2017

1 reference

title

Inflammatory bio-markers and cardiovascular risk prediction (English)

1 reference

5 August 2017

0 references

1 reference

Blake GJ

1

1 reference

PubMed ID

12366601

5 August 2017

Ridker PM

series ordinal

2

1 reference

PubMed ID

12366601

5 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

Journal of Internal Medicine

5 August 2017

1 reference

5 August 2017

252

1 reference

5 August 2017

283-294

1 reference

5 August 2017

4

1 reference

Coronary plaque disruption.

5 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Vulnerable plaque. Relation of characteristics to degree of stenosis in human coronary arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Molecular bases of the acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Leucocyte-endothelial interactions and regulation of leucocyte migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

The combined role of P- and E-selectins in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Detection and localization of tumor necrosis factor in human atheroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF kappa B, and Sp1 transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Interleukin-6 and the acute phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

CD40 signaling and plaque instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

The CD40/CD154 receptor/ligand dyad

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Current concepts of the pathogenesis of the acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Novel clinical markers of vascular wall inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Circulating cell adhesion molecules and death in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Soluble P-selectin and the risk of future cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Soluble CD40L and cardiovascular risk in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Pregnancy-associated plasma protein A as a marker of acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Association between myeloperoxidase levels and risk of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Evaluating novel cardiovascular risk factors: can we better predict heart attacks?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Function of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Generation of C-reactive protein and complement components in atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

C-reactive protein predicts death in patients with previous premature myocardial infarction--a 10 year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Association of C-reactive protein with markers of prevalent atherosclerotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

The effect of aspirin on C-reactive protein as a marker of risk in unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Are statins anti-inflammatory?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Elevated C-reactive protein levels in overweight and obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated With Increased Risk of In-Hospital Coronary Events

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01019.X

10.1046/J.1365-2796.2002.01019.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12366601